Tyrosine-kinase inhibitor - PDFSEARCH.IO - Document Search Engine

Tyrosine-kinase inhibitor
Results: 106

#	Item
1	The TKI Tool More Than Conflict Management ce n Add to Reading List Source URL: www.cppasiapacific.com Language: English - Date: 2016-04-19 00:14:46 Dispute resolution Conflict Personality tests Conflict management Ethnic conflict Organization development Tyrosine-kinase inhibitor Change management ThomasKilmann Conflict Mode Instrument
2	ZAI Lab and Hanmi execute a license agreement to develop novel EGFR targeted therapy for lung cancer in China Shanghai, China and Seoul, Korea, 23th November 2015 – ZAI Lab Limited and Hanmi Pharm. Co., Ltd. announced Add to Reading List Source URL: www.zailaboratory.com Language: English - Date: 2015-11-24 01:50:17 Lung cancer Clinical medicine Cancer Tyrosine kinase inhibitors Boehringer Ingelheim Health T790M Protein kinase inhibitor Epidermal growth factor receptor Non-small-cell lung carcinoma Targeted therapy
3	TECHNOLOGY OFFER A COBALT-BASED STRATEGY FOR TUMOUR TARGETING OF EGFR-INHIBITORS BACKGROUND The development of receptor tyrosine-kinase inhibitors (TKIs) in recent Add to Reading List Source URL: techtransfer.univie.ac.at Language: English - Date: 2015-07-01 06:41:06 Chemistry Organic chemistry Quinazolines Cancer Amines Tyrosine kinase receptors Alkynes Erlotinib Pfizer EGFR inhibitors Epidermal growth factor receptor Tyrosine-kinase inhibitor
4	Letter pubs.acs.org/acsmedchemlett Structural Analysis of the Binding of Type I, I1/2, and II Inhibitors to Eph Tyrosine Kinases Jing Dong,,† Hongtao Zhao,† Ting Zhou,† Dimitrios Spiliotopoulos,† Chitra Rajendra Add to Reading List Source URL: www.biochem-caflisch.uzh.ch Language: English* - Date: 2015-03-30 11:57:31 Tyrosine kinase receptors Protein kinases Mitogen-activated protein kinase BRAF Tyrosine kinase Ephrin B2 EPH receptor A3 Ephrin receptor Receptor tyrosine kinase Tyrosine-kinase inhibitor Kinase P38 mitogen-activated protein kinases
5	Technology Opportunity, Ref. No. UZNovel nanomolar inhibitor of Eph tyrosine kinases New small molecule inhibitors of Eph kinases have been developed which have potential therapeutic application in angiogenesis Add to Reading List Source URL: www.switt.ch Language: English - Date: 2014-02-01 16:41:28 Tyrosine kinase receptors Tyrosine kinase Protein kinase Ephrin Proto-oncogene tyrosine-protein kinase Src Imatinib Kinase C-Met Non-receptor tyrosine kinase Receptor tyrosine kinase
6	CrossMark_Color_Stacked_p Add to Reading List Source URL: www.biochem-caflisch.uzh.ch Language: English - Date: 2014-08-22 09:07:41 Tyrosine kinases Non-receptor tyrosine kinase C-Met inhibitor Fostamatinib Protein kinase Syk ZAP70 Adenosine triphosphate Ligand Linker for Activation of T cells
7	From bloodjournal.hematologylibrary.org at Dana-Farber Cancer Institute on August 23, 2011. For personal use only: Prepublished online June 8, 2011; doi:blood Add to Reading List Source URL: michorlab.dfci.harvard.edu Language: English - Date: 2011-08-23 09:56:20 Pyrimidines Piperazines Pyridines Orphan drugs Chronic myeloid leukemia Chronic myelogenous leukemia Imatinib Philadelphia chromosome Nilotinib Tyrosine-kinase inhibitor ABL Bcr-Abl tyrosine-kinase inhibitor
8	Yuditiya P_Cell-Free mRNA Concentration of Plasminogen Activator Inhibitor-1... Add to Reading List Source URL: repository.ui.ac.id Language: English Blood Anatomy Serine protease inhibitors Plasminogen activator inhibitor-1 Pre-eclampsia Plasminogen activator Tissue plasminogen activator Plasmin Pai Soluble fms-like tyrosine kinase-1
9	Downloaded from genome.cshlp.org on October 7, Published by Cold Spring Harbor Laboratory Press Next-generation sequencing of paired tyrosine kinase inhibitor-sensitive and -resistant EGFR mutant lung cancer cell Add to Reading List Source URL: michorlab.dfci.harvard.edu Language: English - Date: 2013-10-07 10:43:04 Chemistry Biology Organic chemistry Amines Quinazolines Evolutionary biology Molecular biology Genomics Gefitinib Epidermal growth factor receptor Mutation T790M
10	Fitness Conferred by BCR-ABL Kinase Domain Mutations Determines the Risk of Pre-Existing Resistance in Chronic Myeloid Leukemia Kevin Leder1., Jasmine Foo2., Brian Skaggs3, Mercedes Gorre4, Charles L. Sawyers5, Franziska Add to Reading List Source URL: michorlab.dfci.harvard.edu Language: English - Date: 2011-12-13 09:42:07 Medicine Clinical medicine Chemistry Pyrimidines Piperazines Pyridines Organofluorides Orphan drugs Chronic myelogenous leukemia Philadelphia chromosome Bcr-Abl tyrosine-kinase inhibitor Imatinib